Thus, increased HIF-1α promotes ECM remodeling through regulation of collagen deposition by tumor cells [46] and upregulation of metalloproteinases and collagen-modifying enzymes in stromal cells [47]. The gene discussed is HIF1A; the disease is neoplasm.